持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/10/10 | 4,075 | 4,090 | 4,015 | 4,050 | -40 | -1% | 41,000 |
| 2019/10/09 | 4,030 | 4,090 | 4,005 | 4,090 | +25 | +0.6% | 56,900 |
| 2019/10/08 | 4,030 | 4,065 | 3,995 | 4,065 | +85 | +2.1% | 55,500 |
| 2019/10/07 | 4,000 | 4,000 | 3,960 | 3,980 | -40 | -1% | 38,800 |
| 2019/10/04 | 4,000 | 4,025 | 3,940 | 4,020 | ±0 | ±0% | 77,300 |
| 2019/10/03 | 4,020 | 4,025 | 3,970 | 4,020 | -105 | -2.5% | 66,000 |
| 2019/10/02 | 4,150 | 4,200 | 4,110 | 4,125 | -35 | -0.8% | 44,800 |
| 2019/10/01 | 4,130 | 4,170 | 4,125 | 4,160 | +30 | +0.7% | 45,000 |
| 2019/09/30 | 4,090 | 4,190 | 4,090 | 4,130 | -20 | -0.5% | 58,700 |
| 2019/09/27 | 4,175 | 4,175 | 4,090 | 4,150 | -80 | -1.9% | 54,800 |
| 2019/09/26 | 4,275 | 4,290 | 4,215 | 4,230 | -15 | -0.4% | 54,700 |
| 2019/09/25 | 4,300 | 4,300 | 4,195 | 4,245 | ±0 | ±0% | 46,000 |
| 2019/09/24 | 4,220 | 4,295 | 4,220 | 4,245 | +30 | +0.7% | 52,600 |
| 2019/09/20 | 4,240 | 4,255 | 4,185 | 4,215 | +10 | +0.2% | 54,300 |
| 2019/09/19 | 4,155 | 4,240 | 4,155 | 4,205 | +80 | +1.9% | 49,700 |
| 2019/09/18 | 4,185 | 4,185 | 4,095 | 4,125 | -65 | -1.6% | 37,800 |
| 2019/09/17 | 4,190 | 4,195 | 4,160 | 4,190 | ±0 | ±0% | 44,600 |
| 2019/09/13 | 4,170 | 4,200 | 4,110 | 4,190 | +65 | +1.6% | 88,400 |
| 2019/09/12 | 4,190 | 4,200 | 4,110 | 4,125 | +30 | +0.7% | 60,700 |
| 2019/09/11 | 4,035 | 4,105 | 4,000 | 4,095 | +70 | +1.7% | 56,300 |
| 2019/09/10 | 4,040 | 4,040 | 3,990 | 4,025 | +10 | +0.2% | 63,200 |
| 2019/09/09 | 4,040 | 4,040 | 4,000 | 4,015 | -5 | -0.1% | 36,800 |
| 2019/09/06 | 4,085 | 4,085 | 4,005 | 4,020 | -75 | -1.8% | 38,100 |
| 2019/09/05 | 4,050 | 4,135 | 4,030 | 4,095 | +75 | +1.9% | 71,900 |
| 2019/09/04 | 4,050 | 4,085 | 4,020 | 4,020 | -10 | -0.2% | 38,900 |
| 2019/09/03 | 3,990 | 4,050 | 3,980 | 4,030 | +5 | +0.1% | 31,500 |
| 2019/09/02 | 4,145 | 4,150 | 4,020 | 4,025 | -125 | -3% | 34,900 |
| 2019/08/30 | 4,050 | 4,160 | 4,040 | 4,150 | +155 | +3.9% | 85,800 |
| 2019/08/29 | 4,005 | 4,040 | 3,945 | 3,995 | -5 | -0.1% | 43,700 |
| 2019/08/28 | 4,070 | 4,070 | 4,000 | 4,000 | -60 | -1.5% | 34,200 |
| 2019/08/27 | 4,070 | 4,125 | 4,055 | 4,060 | +35 | +0.9% | 36,500 |
| 2019/08/26 | 4,015 | 4,070 | 4,010 | 4,025 | -120 | -2.9% | 71,500 |
| 2019/08/23 | 4,115 | 4,160 | 4,070 | 4,145 | +40 | +1% | 46,400 |
| 2019/08/22 | 4,180 | 4,180 | 4,085 | 4,105 | -65 | -1.6% | 53,900 |
| 2019/08/21 | 4,190 | 4,215 | 4,150 | 4,170 | -85 | -2% | 35,400 |
| 2019/08/20 | 4,205 | 4,255 | 4,175 | 4,255 | +50 | +1.2% | 34,400 |
| 2019/08/19 | 4,255 | 4,255 | 4,190 | 4,205 | -5 | -0.1% | 24,500 |
| 2019/08/16 | 4,195 | 4,240 | 4,170 | 4,210 | +15 | +0.4% | 43,000 |
| 2019/08/15 | 4,190 | 4,195 | 4,150 | 4,195 | -65 | -1.5% | 44,600 |
| 2019/08/14 | 4,255 | 4,300 | 4,220 | 4,260 | +15 | +0.4% | 42,000 |
| 2019/08/13 | 4,255 | 4,280 | 4,215 | 4,245 | -70 | -1.6% | 40,600 |
| 2019/08/09 | 4,330 | 4,385 | 4,305 | 4,315 | +20 | +0.5% | 33,500 |
| 2019/08/08 | 4,325 | 4,325 | 4,265 | 4,295 | -30 | -0.7% | 41,100 |
| 2019/08/07 | 4,330 | 4,355 | 4,290 | 4,325 | -50 | -1.1% | 62,200 |
| 2019/08/06 | 4,335 | 4,375 | 4,285 | 4,375 | -80 | -1.8% | 69,300 |
| 2019/08/05 | 4,430 | 4,520 | 4,370 | 4,455 | -175 | -3.8% | 93,900 |
| 2019/08/02 | 4,540 | 4,675 | 4,530 | 4,630 | +40 | +0.9% | 110,000 |
| 2019/08/01 | 4,590 | 4,595 | 4,520 | 4,590 | +5 | +0.1% | 50,200 |
| 2019/07/31 | 4,545 | 4,625 | 4,540 | 4,585 | -15 | -0.3% | 61,200 |
| 2019/07/30 | 4,590 | 4,605 | 4,545 | 4,600 | ±0 | ±0% | 61,000 |
1351～
1400
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 307,500円 | +3.0% | +27.5% | 2.60% | 19.47倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 鳥居薬 | 451,000円 | +7.1% | -35.0% | 2.66% | 37.29倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 233,400円 | +14.2% | +41.0% | 1.97% | 11.43倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 219,000円 | +21.7% | +999.9% | 0.00% | 9.12倍 | 3.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
